Hedge Fund - Darwin Global Management

Moonlake Immunotherapeutics () 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2023 - Q4 (2023-12-31) $62,762,663 12.31% 1,039,289 $

The displayed share prices are average quarterly stock market prices.